Diabeta prognoze ir atkareiga nu diabeta tipa i nu tuo, cik labi tys teik kontrolāts.
1. tipa diabets ir autoimuna slimeiba, kurys rezultatā organisms naizdalej insulinu, i kurai ir vajadzeiga vysu myužu ilgstūša insulina terapija.
Pareizi izmontojūt insulinu, veseleigi ādūt i regulari aktivi sportojūtīs, 1. tipa diabeta pacienti var ilguok i lobuok dzeivuot.
Tok, ka tū napareizi puorvolda, tys var izraiseit komplikcejis, par pīmāru, sirds slimeibys, nieru slimeibys, nervu būjuojumus i ocu problemys.
2. tipa diabetu izraisa insulina rezistence, i tys bīži ir saisteits ar dzeivisveidu, par pīmāru, aptaukojumu i fiziskuos aktivitatis tryukumu.
Pareizi izmontojūt medikamentus, dietu i fiziskūs aktivitatis, pacienti ar 2. tipa diabetu var lobuok kontrolēt cukra daudzumu asinis i samazynuot komplikceju rysku.
Cytūs gadīņūs ūtra tipa diabetu pat var izmaineit, cīši samazynojūt svoru i izmainejūt dzeivisveidu.
Gestacejis diabets veidojās gryuteibys laikā i parosti izalīk piec dzemdeibu.
Tok sīvītem, kurys ir saslimušys ar grūsšonys diabetu, ir leluoka īspieja saslimt ar 2. tipa diabetu.
Kūpumā diabeta prognoze ir loba, ka tū pareizi puorvolda, tok ir svareigi byut cīši tyvai medicinis apryupis komandai, kab kontrolātu cukra leimini asūt uorā i izdareitu vajadzeigys dzeivisveida puormainis, kab izavaireitu nu gryuteibu.
Zhao XB, Ren GS: Diabetes mellitus and prognosis in women with breast cancer: A systematic review and meta-analysis. Medicine (Baltimore). 2016, 95 (49): e5602.
Ikeda Y, Shimada M, Hasegawa H, Gion T, Kajiyama K, Shirabe K, Yanaga K, Takenaka K, Sugimachi K: Prognosis of hepatocellular carcinoma with diabetes mellitus after hepatic resection. Hepatology. 1998, 27 (6): 1567-71.
Pallisgaard JL, Lindhardt TB, Olesen JB, Hansen ML, Carlson N, Gislason GH: Management and prognosis of atrial fibrillation in the diabetic patient. Expert Rev Cardiovasc Ther. 2015, 13 (6): 643-51.
Borch-Johnsen K: [Insulin-dependent diabetes mellitus--improved prognosis and insurance outlook]. Nord Med. 1992, 107 (8-9): 217-9.
Toyoda H, Kumada T, Nakano S, Takeda I, Sugiyama K, Kiriyama S, Tanikawa M, Sone Y, Hisanaga Y: Impact of diabetes mellitus on the prognosis of patients with hepatocellular carcinoma. Cancer. 2001, 91 (5): 957-63.
Gao RZ, Gu J, Du CZ, Li M: [Impact of diabetes mellitus on clinicopathological factors and prognosis of patients with colorectal cancer.]. Zhonghua Wai Ke Za Zhi. 2010, 48 (2): 88-92.
['Atsaceišona nu: medicinys']
['Itei interneta vītne ir dūmuota tikai izgleiteibys i informacejis īmeslim, i tei nateik skaiteita par medicinys pīduovuojumu voi profesionalu pakolpuojumu.']
['Pīduovuotū informaceju nadreikst lītuot, kab diagnosticātu voi izuorstātu kaidu slimeibu, i tim, kas meklej personeigu mediciniskū padūmu, juosazynoj ar licencātu uorstu.']
['Juopīzeist, ka neironu teikls, kas generej atbiļdis iz vaicuojumim, ir eipaši napareizs, kod runoj par skaitliskū saturu, par pīmāru, par konkretu slimeibu diagnozātūs cylvāku skaitu.']
['Vysod meklejit padumu nu sova uorsta voi cyta kvalificāta uorsta, kab saprostu jiusu slimeibu. Nikod naatsakuortojit profesionalū uorsta padumu voi aizkavejit tū mekliešonu deļtuo, ka esat koč kū izlasiejs itamā interneta vītnē. Ka jiusim ruodīs, ka jiusim var byut uorsteibys uorkuortys situaceja, zvaniet 911 voi īīt tyvuokajā uorstnīceibys centrā.']
['Atsaceišona: autortiesības']
['1998. goda Digitaluo tyukstūšgadis autoru tīseibu lykums, 17 U.S.C. § 512 (DMCA) nūdrūsynoj tīseibu aizstuoviešonu autoru tīseibu turātuojim, kuri skaita, ka materialā, kas pasaruoda iz škārsteikla, ir puorkuoptys jūs tīseibys saskaņā ar ASV autoru tīseibu lykumim. ']
['Ka jius iz lobu tycat, ka kaids saturs voi materials, kas ir pīejams saisteibā ar myusu sātom voi pakolpuojumim, puorkuop jiusu autortiesības, jius (voi jiusu aģents) jiusim var syuteit paziņuojumu, kurā lyugts svīgt itū saturu voi materialu voi bloķēt pīeju tam.']
['Paziņuojumi ir juonūsyuta e-postā (vērtīs sadaļu "Kontakti" e-posta adresei).']
['DMCA prasej, kab jiusu paziņuojumā par īspiejamu autortiesību puorkuopumu byutu īkļauta itei informaceja: (1) ar autortiesībām aizsorguotuo dorba aproksts, kas ir īspiejamuos puorkuopuma objekts; (2) īspiejamuos puorkuopuma satura aproksts i informaceja, kas ir pīteikama, kab ļautu mums atrast saturu; (3) jiusu kontaktinformaceja, tymā skaitā adrese, telefona numurs i e-posta adrese; (4) apstyprynuojums, ka jius asat puorlīcynuots, ka saturs tai, kai ir ībyldts, nav atļauts ar autortiesību eipašnīka voi juo aģenta voi kaida lykuma atbolstu; ']
['5. aplīcynuojumu, ka jiusu informaceja ir pareiza i ka jiusim ir tīseibys izmontuot autortīseibys, kuruos ir nūlīgts lītuot;']
['i 6) fizisks voi elektronisks autortīseibu turātuoja voi personas, kas ir pilnvarota dorbuotīs autortīseibu turātuoja vuordā, paraksts.']
['Lyudzu, syutiet mums e-postu ar sevkuru vaicuojumu/ieteikumu.']
What is prognosis of diabetes?
The prognosis of diabetes varies depending on the type of diabetes and how well it is managed.
Type 1 diabetes is an autoimmune disease where the body does not produce insulin, and it requires lifelong insulin therapy.
With proper management, including insulin injections, healthy diet, and regular exercise, individuals with type 1 diabetes can lead long and healthy lives.
However, if not managed properly, it can lead to complications such as heart disease, kidney disease, nerve damage, and eye problems.
Type 2 diabetes is caused by insulin resistance and is often associated with lifestyle factors such as obesity and lack of physical activity.
With proper management, including medication, diet, and exercise, individuals with type 2 diabetes can improve their blood sugar control and reduce the risk of complications.
In some cases, type 2 diabetes can even be reversed through significant weight loss and lifestyle changes.
Gestational diabetes occurs during pregnancy and usually resolves after delivery.
However, women with gestational diabetes have an increased risk of developing type 2 diabetes later in life.
Overall, the prognosis for diabetes is good if it is managed properly, but it is important to work closely with a healthcare team to monitor blood sugar levels and make necessary lifestyle changes to prevent complications.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
